about
Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cellsThe Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with InflammationTransforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer ProgressionNovel patents and cancer therapies for transforming growth factor-beta and urokinase type plasminogen activator: potential use of their interplay in tumorigenesis.An Overview of Interleukin-17A and Interleukin-17 Receptor A Structure, Interaction and Signaling.Doxycycline Inhibits IL-17-Stimulated MMP-9 Expression by Downregulating ERK1/2 Activation: Implications in Myogenic DifferentiationInflammatory cytokines prime adipose tissue mesenchymal stem cells to enhance malignancy of MCF-7 breast cancer cells via transforming growth factor-β1.Mesenchymal stem cells of different origin: Comparative evaluation of proliferative capacity, telomere length and pluripotency marker expression.Urokinase type plasminogen activator mediates Interleukin-17-induced peripheral blood mesenchymal stem cell motility and transendothelial migration.Characteristics of human adipose mesenchymal stem cells isolated from healthy and cancer affected people and their interactions with human breast cancer cell line MCF-7 in vitro.Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activating ERK1,2.The inhibition of periodontal ligament stem cells osteogenic differentiation by IL-17 is mediated via MAPKs.Metabolic Plasticity of Stem Cells and Macrophages in Cancer.Coordinated time-dependent modulation of AMPK/Akt/mTOR signaling and autophagy controls osteogenic differentiation of human mesenchymal stem cells.SKIP Downregulation Increases TGF-β1-Induced Matrix Metalloproteinase-9 Production in Transformed Keratinocytes.Combined effect of IL-17 and blockade of nitric oxide biosynthesis on haematopoiesis in mice.IL-17 and FGF signaling involved in mouse mesenchymal stem cell proliferation.Regulation of Mesenchymal Stem Cell Differentiation by Transforming Growth Factor Beta Superfamily.Lipopolysaccharide can modify differentiation and immunomodulatory potential of periodontal ligament stem cells via ERK1,2 signaling.Mesenchymal stromal cell engagement in cancer cell epithelial to mesenchymal transition.p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.p53 Functions in Adipose Tissue Metabolism and HomeostasisMesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton's jellyAdipoinductive effect of extracellular matrix involves cytoskeleton changes and SIRT1 activity in adipose tissue stem/stromal cellsImproving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell nicheIL-33 guides osteogenesis and increases proliferation and pluripotency marker expression in dental stem cellsStratifying nutritional restriction in cancer therapy: Next stop, personalized medicine
P50
Q26996742-F00C0509-0EDE-4DE5-B4F0-B91B94A38030Q28073691-D1D6DBD0-1CBF-4F4F-AB9E-801531B8AB9EQ28083526-C071D63E-B45C-43B0-906A-D2A97C1042EAQ38211697-8C2C8A03-384B-41FD-A78E-4B5DA3278E92Q38491895-22564D99-0FF8-46CB-982E-8F53031FE525Q38723327-B1920D35-EF18-4068-8AE3-53D3A4FA5EDCQ38799898-8642CEBA-F518-49F3-804B-3B8C1E60CED2Q38832230-48141F3C-7A62-463F-ADEF-5304C239F387Q38937047-C0068D45-25B5-469D-AE99-ACA92103540BQ39071952-EA0E6001-8388-475E-ACA0-C743EC9A9A74Q39404968-34F0E0EE-2C63-487E-B189-29B89234FC66Q40156794-C9617E12-6E18-4AC7-B33F-8CA602EC8E02Q41352553-1D571F1A-BD92-4BA5-B94F-CEB1AFCD8DB7Q41927956-7048EFCE-B090-4302-A20B-5498BB646479Q42209867-3D2C8F28-CF8C-47D9-B139-753F5360B6E3Q43183940-444E9953-E3FA-41BD-9EB3-A81761519C18Q46378093-301AEFAB-1394-40A4-B12F-847988B08CF0Q47284578-D24A6EE4-B9E0-4768-BFCB-B08BE77DED7AQ47335104-9EDA35D1-63D1-4A74-82B5-ABD8F233A124Q48162218-54050FD1-7B3B-43C1-80C7-00808F449F26Q51761242-3A7187C9-E45C-43F1-8975-522CD916FB8CQ57161298-B45FF1DB-7F7C-42C4-A6BF-F169E6704FDAQ86913938-1A132DF3-41CF-4D82-A14B-C6CEB4EEEAC5Q91352116-F1F938E2-3117-477C-BECB-27830B17E56AQ92591448-CE04CE90-DD29-46DC-B627-16310E7BD6DEQ93087699-B253FEA4-444E-4532-9FED-926A768DD0D3Q96017803-2CBD7CBE-4298-46A3-ADD1-8D34CE09AA83
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-3423-533X
@en
name
Jelena Kocic
@ast
Jelena Kocic
@en
Jelena Kocic
@es
Jelena Kocic
@nl
type
label
Jelena Kocic
@ast
Jelena Kocic
@en
Jelena Kocic
@es
Jelena Kocic
@nl
prefLabel
Jelena Kocic
@ast
Jelena Kocic
@en
Jelena Kocic
@es
Jelena Kocic
@nl
P106
P31
P496
0000-0002-3423-533X